WebAstellas has put down $18 million upfront and promised up to $1.6 billion in milestone and royalty payments to tap into Dyno Therapeutics’ adeno-associated virus vector … WebDec 1, 2024 · Astellas is essentially hiring Dyno to engineer viral capsids for gene therapy, to the tune of nearly $2 billion. The Tokyo firm is paying Cambridge-based Dyno $18 million up front with the ...
Dyno Therapeutics scores another major partner in Astellas
WebDec 2, 2024 · “Dyno and Astellas each bring unique strengths to this collaboration, together enabling more rapid creation of new therapies for patients with great unmet need,” said Eric Kelsic, co-founder and CEO of Dyno Therapeutics. “This partnership demonstrates the flexibility of Dyno’s platform to precisely design the delivery properties of gene ... Web“Astellas Entity” means, as applicable, (a) Astellas, (b) any of Astellas’ Affiliates or (c) any direct or indirect sublicensee or contractor of Astellas or any of Astellas’ Affiliates (other than any Frequency Entity). Section 1.10. “Astellas Indemnitees” has the meaning set forth in Section 14.01 (Indemnification by Frequency) hereof. gulf coast title brooksville
Eric Kelsic: Origins of Dyno and the Future of Gene Therapy
WebDec 2, 2024 · Astellas Pharma has signed an option and licence agreement with Dyno Therapeutics to develop next-generation adeno-associated virus (AAV) gene therapy … WebHappy to be a part of this exciting partnership with Dyno Therapeutics to develop next generation AAV capsids. Amazing news! Vivian Chow on LinkedIn: Astellas, Dyno Launch Up-to-$1.6B+ Gene ... WebDec 2, 2024 · Gene therapy biotech Astellas is turning to Dyno Therapeutics to make their treatments safer. With a massive potential value, a lot rides on the deal, especially for Astellas. The Japanese pharma has faced a tough run since its $3 billion buy of Audentes two years ago. The deal brought Astellas AT132, a gene therapy in development for a … gulf coast tires summerdale al